Tryptophan — Benefits Deep Dive

Deep-Dive Articles

Back to Table of Contents

Table of Contents

1. Deep-Dive Articles
2. Why Tryptophan Produces Effects Across Many Systems
3. The Thanksgiving Turkey Myth
4. How Tryptophan Supplements Performed for Sleep in Pooled Trials
5. What Trials Report About Tryptophan, 5-HTP and Mood
6. Research Papers: Sleep & Melatonin
7. Research Papers: Mood & Serotonin
8. Research Papers: Niacin Synthesis & Kynurenine Pathway
9. Research Papers: Cognitive Function & Inflammation
10. Research Papers: Cross-Cutting (Mechanism, Safety, EMS)
11. External Authoritative Resources
12. Connections
13. Featured Videos

Why Tryptophan Produces Effects Across Many Systems

Most amino acids do one thing very well — they get incorporated into protein. Tryptophan does that too, but its real significance is as the chemical raw material for three of the most consequential signaling molecules in human physiology, each operating through a fundamentally different mechanism. Each of the three maps to a distinct category of clinical effect.

1. Monoamine neurotransmitter precursor (serotonin) — tryptophan is the unique precursor for serotonin (5-hydroxytryptamine, 5-HT), the master mood neurotransmitter. The rate-limiting enzyme is tryptophan hydroxylase, which exists as TPH1 in the gut and TPH2 in the brain. This pathway is responsible for the mood, anxiety, appetite, and pain-tolerance effects of tryptophan supplementation.
2. Hormone precursor (melatonin) — serotonin in the pineal gland is acetylated by AANAT (arylalkylamine N-acetyltransferase, the night-light-suppressed gateway enzyme) and methylated by HIOMT (hydroxyindole-O-methyltransferase) to yield melatonin, the master circadian hormone. This pathway accounts for the sleep-onset and circadian-realignment effects.
3. Vitamin / cofactor precursor (nicotinamide adenine dinucleotide via niacin) — the kynurenine pathway, which catabolizes the other 95% of dietary tryptophan, ultimately yields niacin (vitamin B3) and nicotinamide adenine dinucleotide (NAD+), the universal redox cofactor. This is the metabolic basis for the historical pellagra story and the inefficient 60:1 conversion ratio.

The complication — and the reason tryptophan biology has exploded as a research topic over the last twenty years — is that the kynurenine pathway is regulated by inflammation. The first and rate-limiting enzyme, indoleamine 2,3-dioxygenase (IDO), is strongly induced by interferon-gamma. The hepatic equivalent, tryptophan 2,3-dioxygenase (TDO), is induced by cortisol. When the body is inflamed or chronically stressed, both enzymes upregulate, dietary tryptophan is shunted into kynurenine instead of serotonin, and the downstream kynurenine pathway produces both the neuroprotective kynurenic acid branch and the neurotoxic quinolinic acid branch. The latter is a direct N-methyl-D-aspartate receptor agonist and an excitotoxin. This inflammation-depression-neurodegeneration link is one of the most active areas in contemporary psychiatric and neurological research.

Two practical implications follow. First, supplementing tryptophan or 5-HTP in the setting of active inflammation may not deliver the expected serotonin boost — the substrate gets pulled into kynurenine instead. Researchers in this field propose that, in that setting, the inflammation may limit serotonin production more than the supply of precursor does; this is a hypothesis. Second, the same biology explains why depression is so prevalent in chronic inflammatory disease (rheumatoid arthritis, inflammatory bowel disease, hepatitis C) and why a major depressive episode follows interferon-alpha therapy in about one in four people treated for chronic hepatitis C (a meta-analysis of 26 observational studies, Udina 2012) — the kynurenine pathway is being pharmacologically forced open.

A 2021 meta-analysis of 101 studies with 10,912 participants (Marx) compared people with major depression, bipolar disorder or schizophrenia with controls. Tryptophan and kynurenine were lower in all three conditions. The kynurenine-to-tryptophan ratio was higher in major depression and schizophrenia, and the ratio of kynurenic acid to quinolinic acid was lower in the mood disorders (major depression and bipolar disorder). The authors read this as a shift of tryptophan metabolism from serotonin toward the kynurenine pathway. These studies compare groups of people, so they do not show whether the shift causes the illness or results from it.

The role of serotonin itself is argued over. A systematic umbrella review (Moncrieff, Molecular Psychiatry 2023) gathered 17 studies and reported that the main areas of serotonin research "provide no consistent evidence of there being an association between serotonin and depression, and no support for the hypothesis that depression is caused by lowered serotonin activity or concentrations". In the same journal, other researchers (Jauhar 2023) replied that this conclusion is overstated, citing weaknesses in the review's methods, selective reporting of data and errors in interpreting the drug findings.

Back to Table of Contents

The Thanksgiving Turkey Myth

The single most widely repeated tryptophan factoid in American popular culture — that turkey is exceptionally high in tryptophan and that this is why people fall asleep on the couch after Thanksgiving dinner — is mechanistically wrong on multiple counts.

First, turkey is unremarkable for tryptophan content. Per 100 g, USDA FoodData Central lists roasted turkey meat at about 310 mg of tryptophan. Roasted chicken meat is slightly higher at about 338 mg. Roasted pork loin (about 278 mg), cooked salmon (about 248 mg) and broiled beef sirloin (about 191 mg) are in the same general range or somewhat lower, while whole raw egg (about 167 mg), cooked black beans (about 105 mg) and cooked lentils (about 81 mg) carry clearly less. Pumpkin seeds at ~575 mg per 100 g and cheddar cheese at ~320 mg per 100 g both beat turkey. There is nothing tryptophan-distinctive about turkey at all.

Second, dietary tryptophan from a mixed-protein meal does not produce a meaningful brain serotonin surge. Tryptophan competes with the other large neutral amino acids (leucine, isoleucine, valine, tyrosine, phenylalanine) for the LAT1 transporter at the blood-brain barrier. Eating a protein-rich meal raises plasma tryptophan, but it raises the competing branched-chain amino acids (BCAAs) more, so the ratio of tryptophan to its competitors actually goes down. A pure-carbohydrate meal, paradoxically, does raise the ratio (insulin clears the branched-chain amino acids into muscle without affecting tryptophan as much), which is why purified L-tryptophan supplementation is taken on an empty stomach or with a small carbohydrate, not with a steak.

Third, the actual cause of post-Thanksgiving sleepiness is the meal itself, not turkey-specific tryptophan. Large mixed meals trigger the postprandial parasympathetic response (the "rest and digest" shift), divert blood flow to the splanchnic circulation, and produce a measurable transient cognitive slowdown. Adding alcohol amplifies the effect. Add the cumulative effect of holiday social stress, often-disrupted sleep the night before, and afternoon timing that coincides with the natural early-afternoon dip in alertness, and the sleepiness is fully explained without invoking any tryptophan-specific mechanism.

The myth is so persistent that it shows up in medical school lectures and in popular nutrition books. It does not fit the mechanisms described above; the Deep-Dive Articles at the top of this page cover them in more detail.

Back to Table of Contents

How Tryptophan Supplements Performed for Sleep in Pooled Trials

A 2022 meta-analysis (Sutanto, Nutrition Reviews) collected 18 articles and analyzed data from 4 of them. Tryptophan supplements shortened wake after sleep onset, the time spent awake after first falling asleep. Groups taking 1 g or more a day spent less of that time awake than groups taking under 1 g (28.91 versus 56.55 minutes). The supplements did not change the other sleep measures. An older review (Hartmann 1982) described 40 controlled studies and reported that doses of 1 g or more raised rated sleepiness and shortened the time taken to fall asleep, with mixed results in people with severe insomnia or serious medical or psychiatric illness.

Back to Table of Contents

What Trials Report About Tryptophan, 5-HTP and Mood

• Healthy adults. A systematic review of 11 randomized trials (Kikuchi 2021) found 4 showing effects on negative feelings and happy feelings compared with control groups, and no effect on aggressive feelings. The authors concluded that 0.14–3 g a day on top of usual meals can be expected to improve mood in healthy people, and that the best amount is still unsettled.
• 5-HTP in depression. A 2020 meta-analysis (Javelle) of 13 investigations, 7 in the full analysis, reported a remission rate of 0.65 and a large effect on questionnaire scores (Hedges' g 1.11). The authors rated current studies as "relatively weak", with few including placebo groups.
• The Cochrane review. Shaw 2002 located 108 trials of tryptophan and 5-HTP for depression, and only 2, with 64 patients, met its quality standard. Those favored the supplements over placebo (Peto odds ratio 4.10, 95% confidence interval 1.28–13.15), but the evidence was "of insufficient quality to be conclusive". The review also states that the possible link between these substances and the potentially fatal eosinophilia-myalgia syndrome "has not been elucidated".

Back to Table of Contents

Research Papers: Sleep & Melatonin

1. Hartmann E (1982). Effects of L-tryptophan on sleepiness and on sleep. Journal of Psychiatric Research. 17(2):107-113. — PubMed PMID: 6764927
2. Silber BY, Schmitt JA (2010). Effects of tryptophan loading on human cognition, mood, and sleep. Neuroscience & Biobehavioral Reviews. 34(3):387-407. — PubMed PMID: 19715722
3. Sutanto CN, Loh WW, Kim JE (2022). The impact of tryptophan supplementation on sleep quality: a systematic review, meta-analysis, and meta-regression. Nutrition Reviews. 80(2):306-316. — PubMed PMID: 33942088
4. AANAT (arylalkylamine N-acetyltransferase) as the pineal rate-limiting enzyme — PubMed: AANAT pineal
5. HIOMT (hydroxyindole-O-methyltransferase) and pineal melatonin synthesis — PubMed: HIOMT melatonin synthesis
6. 5-HTP vs L-tryptophan for sleep onset latency (Soulairac trials) — PubMed: 5-HTP vs L-tryptophan sleep
7. Exogenous melatonin for circadian rhythm sleep-wake disorders — PubMed: Exogenous melatonin meta-analysis
8. L-tryptophan eosinophilia-myalgia syndrome (EMS) 1989 outbreak — PubMed: EMS 1989 outbreak
9. EMS contamination traced to one Japanese manufacturer: cause and identification — PubMed: EMS contamination cause
10. Tryptophan and slow-wave sleep architecture — PubMed: Tryptophan slow-wave sleep
11. Cubero J et al., tryptophan-enriched infant formula and sleep onset — PubMed: Cubero infant formula
12. Melatonin as antioxidant and mitochondrial protector (Reiter) — PubMed: Reiter melatonin antioxidant
13. Tryptophan vs melatonin head-to-head for insomnia in elderly — PubMed: Tryptophan vs melatonin elderly

Back to Table of Contents

Research Papers: Mood & Serotonin

1. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR (1990). Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Archives of General Psychiatry. 47(5):411-418. — PubMed PMID: 2184795
2. Walther DJ, Peter JU, Bashammakh S, Hörtnagl H, Voits M, Fink H, Bader M (2003). Synthesis of serotonin by a second tryptophan hydroxylase isoform (identification of the brain isoform, TPH2). Science. 299(5603):76. — PubMed PMID: 12511643
3. Acute tryptophan depletion paradigm meta-analysis — PubMed: Acute tryptophan depletion meta-analysis
4. Shaw K, Turner J, Del Mar C (2002). Tryptophan and 5-hydroxytryptophan for depression. Cochrane Database of Systematic Reviews. (1):CD003198. — PubMed PMID: 11869656
5. Kikuchi AM, Tanabe A, Iwahori Y (2021). A systematic review of the effect of L-tryptophan supplementation on mood and emotional functioning. Journal of Dietary Supplements. 18(3):316-333. — PubMed PMID: 32272859
6. Javelle F, Lampit A, Bloch W, Häussermann P, Johnson SL, Zimmer P (2020). Effects of 5-hydroxytryptophan on distinct types of depression: a systematic review and meta-analysis. Nutrition Reviews. 78(1):77-88. — PubMed PMID: 31504850
7. Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA (2023). The serotonin theory of depression: a systematic umbrella review of the evidence. Molecular Psychiatry. 28(8):3243-3256. — PubMed PMID: 35854107
8. Jauhar S, Arnone D, Baldwin DS et al. (2023). A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression. Molecular Psychiatry. 28(8):3149-3152. — PubMed PMID: 37322065
9. Carbohydrate-induced insulin release and large-neutral-amino-acid clearance (Wurtman) — PubMed: Wurtman carbohydrate-tryptophan
10. LAT1 (large neutral amino acid transporter) at blood-brain barrier and tryptophan competition — PubMed: LAT1 BBB transport
11. Tryptophan supplementation for premenstrual dysphoric disorder — PubMed: Tryptophan for PMDD
12. SSRI mechanism of action and the serotonin hypothesis of depression — PubMed: SSRI mechanism review
13. Tryptophan for seasonal affective disorder (SAD) — PubMed: Tryptophan SAD
14. Aggression, impulsivity, and tryptophan depletion — PubMed: Tryptophan and aggression
15. 5-HTP for depression: systematic review — PubMed: 5-HTP depression
16. Tryptophan and obsessive-compulsive disorder (OCD) — PubMed: Tryptophan and OCD

The Delgado 1990 experiment in plain terms: 21 patients in remission on antidepressants ate a low-tryptophan diet for 24 hours and then took a tryptophan-free amino acid drink. Total tryptophan in the blood fell 87% and free tryptophan 91%. Fourteen of the 21 had a depressive relapse, and they returned to remission over 24 to 48 hours once back on regular food. The control test produced no significant behavioral effects. The plain result of the Shaw 2002 Cochrane review is in the section What Trials Report About Tryptophan, 5-HTP and Mood.

Back to Table of Contents

Research Papers: Niacin Synthesis & Kynurenine Pathway

1. Goldberger J classic pellagra trials — PubMed: Goldberger pellagra
2. Krehl WA, Teply LJ, Sarma PS, Elvehjem CA (1945). Growth-retarding effect of corn in nicotinic acid-low rations and its counteraction by tryptophane (an animal growth study, not a human pellagra trial). Science. 101(2628):489-490. — PubMed PMID: 17735529
3. 60:1 tryptophan to niacin equivalent (NE) conversion ratio — PubMed: Niacin equivalent conversion
4. Hartnup disease (SLC6A19 mutation) and tryptophan transport defect — PubMed: Hartnup disease
5. Indoleamine 2,3-dioxygenase (IDO) and interferon-gamma induction — PubMed: IDO induction
6. Tryptophan 2,3-dioxygenase (TDO) hepatic regulation and cortisol — PubMed: TDO hepatic
7. Kynurenine pathway as central regulator of inflammation (Schwarcz review) — PubMed: Schwarcz kynurenine review
8. Quinolinic acid as NMDA receptor agonist and excitotoxin — PubMed: Quinolinic acid NMDA
9. Kynurenic acid as neuroprotective NMDA antagonist — PubMed: Kynurenic acid neuroprotection
10. NAD+ biosynthesis from tryptophan via de novo pathway — PubMed: NAD+ from tryptophan
11. Pellagra-like syndrome in carcinoid tumor (tryptophan diversion) — PubMed: Carcinoid pellagra
12. 3-hydroxykynurenine and oxidative stress — PubMed: 3-hydroxykynurenine

Back to Table of Contents

Research Papers: Cognitive Function & Inflammation

1. Maes M et al. The inflammation and oxidative & nitrosative stress (IO&NS) hypothesis of depression — PubMed: Maes inflammation hypothesis
2. Interferon-alpha induced depression and kynurenine pathway activation — PubMed: IFN-alpha depression
3. Udina M, Castellví P, Moreno-España J et al. (2012). Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. Journal of Clinical Psychiatry. 73(8):1128-1138. — PubMed PMID: 22967776
4. Marx W, McGuinness AJ, Rocks T et al. (2021). The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies. Molecular Psychiatry. 26(8):4158-4178. — PubMed PMID: 33230205
5. Quinolinic acid in Alzheimer's disease brain — PubMed: Quinolinic acid in Alzheimer's
6. Kynurenine pathway in Huntington's disease — PubMed: Kynurenine in Huntington's
7. Erhardt S, Lim CK, Linderholm KR et al. (2013). Connecting inflammation with glutamate agonism in suicidality (quinolinic acid in the cerebrospinal fluid of 64 medication-free suicide attempters and 36 controls). Neuropsychopharmacology. 38(5):743-752. — PubMed PMID: 23299933
8. Kynurenic-to-quinolinic acid ratio as biomarker in depression — PubMed: Kynurenic-to-quinolinic ratio biomarker
9. Tryptophan depletion and long-term memory consolidation — PubMed: Depletion and memory
10. Indoleamine pathway and tumor immune escape — PubMed: IDO and tumor immunity
11. Schizophrenia and elevated kynurenic acid — PubMed: Schizophrenia kynurenic acid
12. Cognitive flexibility and acute tryptophan depletion in healthy volunteers — PubMed: ATD cognitive flexibility
13. Microglial IDO induction in chronic neuroinflammation — PubMed: Microglial IDO
14. IDO1 inhibitors (epacadostat) in clinical oncology trials — PubMed: IDO inhibitors oncology
15. Long GV, Dummer R, Hamid O et al. (2019). Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study. Lancet Oncology. 20(8):1083-1097. — PubMed PMID: 31221619

Blocking the IDO1 enzyme has been tested in cancer. In the ECHO-301 phase 3 trial, 706 people with unresectable stage III or IV melanoma were assigned to epacadostat (an IDO1 blocker) plus pembrolizumab, or placebo plus pembrolizumab. Median progression-free survival was 4.7 versus 4.9 months (hazard ratio 1.00), overall survival did not differ significantly, and the study was stopped after its second interim analysis.

Back to Table of Contents

Research Papers: Cross-Cutting (Mechanism, Safety, EMS)

1. Topic search: L-tryptophan, eosinophilia-myalgia syndrome (EMS) and the FDA recall history — PubMed search: FDA EMS recall
2. EBT (1,1-ethylidenebis-tryptophan) Peak 97 / Peak 200 contamination chemistry — PubMed: EBT contamination chemistry
3. Return of L-tryptophan to the US over-the-counter market (a 2011 report dates the lifting of the FDA ban to 2005) — PubMed: L-tryptophan market return
4. Allen JA, Peterson A, Sufit R et al. (2011). Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan. Arthritis & Rheumatism. 63(11):3633-3639. — PubMed PMID: 21702023
5. Serotonin syndrome from combined serotonergic agents — PubMed: Serotonin syndrome
6. Tryptophan plasma concentration and circadian variation — PubMed: Diurnal tryptophan
7. Tryptophan and pregnancy / lactation safety — PubMed: Pregnancy and tryptophan
8. Tryptophan as fishmeal additive and broiler-chicken performance (food-supply niacin angle) — PubMed: Tryptophan in feed
9. WHO/FAO essential amino acid requirements (2007 report) — PubMed: WHO/FAO 2007 report
10. Vegan diet and tryptophan adequacy — PubMed: Vegan tryptophan adequacy
11. Topic search: tryptophan amino acid reviews — PubMed search: tryptophan reviews

Eosinophilia-myalgia syndrome starts with muscle pain and a raised count of eosinophils (a type of white blood cell), followed by long-lasting nerve damage and hardened skin. The 1989 epidemic was linked to L-tryptophan from a single source, and the number of cases fell quickly after the FDA ban on sale. Allen and colleagues reported in 2011 a new case associated with L-tryptophan, writing that no new cases had been described since the ban was lifted in 2005. The full history is on the page Eosinophilia-Myalgia Syndrome: The 1989 L-Tryptophan Outbreak.

Back to Table of Contents

External Authoritative Resources

• National Academies — Dietary Reference Intakes: Protein and Amino Acids (2005), Chapter 10 — a fixed 2005 reference report
• U.S. National Institutes of Health (NIH) Office of Dietary Supplements — Fact Sheet Index (search "tryptophan", "5-HTP", "melatonin", "niacin")
• MedlinePlus — Herbs and Supplements index (this L-tryptophan link now opens the general index)
• MedlinePlus — Herbs and Supplements index (this 5-HTP link now opens the general index)
• PubMed — All research on tryptophan (~60,000+ papers)
• PubMed — Kynurenine pathway research

Back to Table of Contents

Connections

• All Amino Acids
• Tryptophan (Main Page)
• Tryptophan for Sleep & Melatonin
• Tryptophan for Mood & Serotonin
• Tryptophan and Niacin Synthesis
• Tryptophan and Cognitive Function
• Tyrosine
• Phenylalanine
• Glycine
• Vitamin B3 (Niacin)
• Vitamin B6
• Magnesium
• Depression
• Anxiety
• Insomnia
• Sleep Hygiene
• Gut-Brain Axis
• Brain Fog
• History
• Sources

Back to Table of Contents

Featured Videos

×